Paratek Pharmaceuticals, Inc. Recorded Big Gain
Tue, Mar 21, 2023 at 07:07 PM
Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ) jumped higher at $1.86, representing a gain of 35.8%. The stock appeared on our News Catalysts scanner on Wed, Mar 08, 2023 at 09:26 AM in the 'EARNINGS' category. From Tue, Mar 07, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
About Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ)
Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.
Top 10 Gainers:
- U.S. Xpress Enterprises, Inc. (USX:NYSE), 298.67%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 92.31%
- Impac Mortgage Holdings, Inc. (IMH:NYSEMKT), 89.81%
- Quince Therapeutics Inc Com (QNCX:NASDAQ), 71.1%
- Pear Therapeutics Inc. (PEAR:NASDAQ), 59.88%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 39.48%
- ImmunityBio Inc. (IBRX:NASDAQ), 36.3%
- Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ), 35.77%
- SCYNEXIS, Inc. (SCYX:NASDAQ), 35.65%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 33.33%